Frontlight ResearchEarly access
Coronary artery disease trials in United Kingdom
45 of 76 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Not yet taking people in United KingdomStudy of the BioRISE Biolimus Drug-Coated Balloon Versus the SELUTION SLR Sirolimus-Coated Balloon in De Novo Coronary Lesions, With a Single-Arm In-Stent Restenosis Cohort (SUNRISE)
- Where
- Bournemouth, Bristol
- Age
- 18 years and over
- People
- 443
- Run by
- Biosensors Europe SA
See details and how to joinNCT07938060 - No phaseEnrolling by invitationOptical Coherence Tomography in Acute Vessel Evaluation
- Where
- Bournemouth, Leeds, London, Oxford
- Age
- 18 years and over
- People
- 3,000 worldwide
- Run by
- Aarhus University Hospital Skejby
See details and how to joinNCT07422688 - No phaseTaking peopleULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic Coronary Syndrome)
- Where
- Harrow
- Age
- 18 years and over
- People
- 225
- Run by
- London North West Healthcare NHS Trust
See details and how to joinNCT07696533 - No phaseTaking peopleA Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- Where
- Leicester, London, Newcastle, Oxford
- Age
- 18 years to 85 years
- People
- 700 worldwide
- Run by
- Fundación EPIC
See details and how to joinNCT07286578 - Phase 3Not yet taking people in United KingdomA Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
- Where
- London
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- EBI Anti Sepsis BV
See details and how to joinNCT07357675 - No phaseNot yet taking people in United KingdomIntracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
- Where
- London
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Cryotherapeutics SA
See details and how to joinNCT06939374 - No phaseTaking peopleMultivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina
- Where
- Basildon, Bournemouth, Brighton, London, Portsmouth, Southampton
- Age
- 18 years and over
- People
- 50
- Run by
- Imperial College London
See details and how to joinNCT06400290 - No phaseTaking peoplePrevail Global Study
- Where
- Newcastle upon Tyne
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Medtronic Vascular
See details and how to joinNCT06535854 - No phaseTaking peopleStudy of Lesion-Specific Invasive Haemodynamic Angina Thresholds
- Where
- Basildon, Bournemouth, London
- Age
- 18 years and over
- People
- 60
- Run by
- Imperial College London
See details and how to joinNCT07386418 - Phase 4Not yet taking people in United KingdomSpontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial
- Where
- Leicester
- Age
- 18 years and over
- People
- 3,518 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07683923 · EU 2025-523985-26-00 - Phase 2Taking peopleDose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- Where
- London
- Age
- 18 years to 80 years
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07830719 · EU 2026-525974-21-00 - No phaseNot yet taking people in United KingdomCoronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy
- Where
- Bristol, Liverpool, London, Oxford, Poole, Westcliff-on-Sea
- Age
- 18 years and over
- People
- 50
- Run by
- Imperial College London
See details and how to joinNCT07865364 - No phaseTaking peoplePredicting Plaque Growth Using Blood Flow Stress Markers: A Proof-of-Concept Study
- Where
- London
- Age
- 40 years and over
- People
- 270
- Run by
- Queen Mary University of London
See details and how to joinNCT07864051 - Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Bradford, Brighton, Bristol, Cambridge, Canterbury, Edinburgh, Hull, Leeds, Leicester, London, Manchester, Norwich, Plymouth, Sheffield, Southampton, Truro, Wakefield
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01 - No phaseNot yet taking people in United KingdomEffectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
- Where
- Leicester
- Age
- 18 years and over
- People
- 80
- Run by
- University of Leicester
See details and how to joinNCT07500948 - No phaseTaking peopleEfficacy of the COronary SInus Reducer in Patients With Refractory Angina II
- Where
- Basildon, Birmingham, Bristol, Cambridge, Dorchester, Kettering, Leicester, Liverpool, London, Newcastle upon Tyne, Nottingham, Oxford, Poole, Taunton
- Age
- 18 years and over
- People
- 380 worldwide
- Run by
- Shockwave Medical, Inc.
See details and how to joinNCT05102019 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Birmingham, Bradford, Coventry, Derby, Dorchester, Liverpool, London, Londonderry, Salford, Shrewsbury, Stoke-on-Trent, Wolverhampton
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 1Taking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Birmingham, Cambridge, Edinburgh, London, Manchester, Nottingham
- Age
- 18 years to 70 years
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730 - No phaseTaking peopleMicrovascular Coronary Rehabilitation For Improving Treatment - Feasibility Study
- Where
- Bath, Bristol
- Age
- 18 years and over
- People
- 40
- Run by
- Royal United Hospitals Bath NHS Foundation Trust
See details and how to joinNCT06681896 - No phaseNot yet taking people in United KingdomThe Use of Artificial Intelligence-Enhanced Electrocardiograms in the Chest Pain Clinic to Risk Stratify Patients, Provide Rapid Reassurance and Enable a Low-Cost Clinical Pathway
- Where
- London
- Age
- 18 years and over
- People
- 4,000
- Run by
- Jamil Mayet
See details and how to joinNCT07757425 - No phaseNot yet taking people in United KingdomExercise Therapy for Women With ANOCA
- Where
- Basildon, Bath, Cambridge, Glasgow, Leeds, London, Newcastle upon Tyne, Nottingham, Sunderland
- Age
- 18 years and over
- People
- 76
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07733986 - Phase 2/3Taking peopleComparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study
- Where
- Oxford
- Age
- 18 years and over
- People
- 60
- Run by
- Oxford University Hospitals NHS Trust
See details and how to joinNCT07687576 - No phaseTaking peopleSixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study
- Where
- Edinburgh, Livingston
- Age
- 18 years and over
- People
- 19,500
- Run by
- University of Edinburgh
See details and how to joinNCT07636642 - No phaseTaking peopleCTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)
- Where
- London
- Age
- 18 years and over
- People
- 1,000
- Run by
- Queen Mary University of London
See details and how to joinNCT07165678 - No phaseTaking peopleLow-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells
- Where
- Cambridge
- Age
- 18 years and over
- People
- 24
- Run by
- Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT07610538